These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 18579495)

  • 1. Ventricular-arterial coupling in patients with heart failure treated with cardiac resynchronization therapy: may we predict the long-term clinical response?
    Zanon F; Aggio S; Baracca E; Pastore G; Corbucci G; Boaretto G; Braggion G; Piergentili C; Rigatelli G; Roncon L
    Eur J Echocardiogr; 2009 Jan; 10(1):106-11. PubMed ID: 18579495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients.
    Klimusina J; De Boeck BW; Leenders GE; Faletra FF; Prinzen F; Averaimo M; Pasotti E; Klersy C; Moccetti T; Auricchio A
    Eur J Heart Fail; 2011 Feb; 13(2):186-94. PubMed ID: 21106543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Chan CK; Chan YS; Zhang Q; Lin H; Yip GW; Kum LC; Kong SL; Zhang Y; Sanderson JE
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1058-65. PubMed ID: 15363081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy.
    Oyenuga O; Hara H; Tanaka H; Kim HN; Adelstein EC; Saba S; Gorcsan J
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):132-40. PubMed ID: 20159638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.
    Soliman OI; Theuns DA; Geleijnse ML; Anwar AM; Nemes A; Caliskan K; Vletter WB; Jordaens LJ; Cate FJ
    Europace; 2007 Feb; 9(2):113-8. PubMed ID: 17218390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.
    Bertini M; Delgado V; den Uijl DW; Nucifora G; Ng AC; van Bommel RJ; Borleffs CJ; Boriani G; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):86-93. PubMed ID: 19920028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy.
    Vecera J; Penicka M; Eriksen M; Russell K; Bartunek J; Vanderheyden M; Smiseth OA
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):624-32. PubMed ID: 26921169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.